IP Library Granted Patent US 10,300,101
Granted Patent B2
US 10,300,101 · App. 15/157,243 · Granted May 28, 2019

Methods and compositions for enhancing or maintaining fertility

Inventors: Amy L. Heaton (Salt Lake City, UT); Mitchell K. Friedlander (Salt Lake City, UT); Dennis Gay (Salt Lake City, UT)
Assignee: Quality IP Holdings, LLC
A61K36/538A23L33/105A23L33/175A61K9/0053A61K31/198A61K31/4015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,300,101
App. No.
15/157,243
Granted
May 28, 2019
Kind
B2
Abstract

Embodiments of the invention generally relate to methods and supplements for increasing, enhancing, or maintaining fertility in a human being.

Claims (17)

1. A method for increasing, enhancing, or maintaining fertility in a human being in need thereof, the method comprising:

providing an oral nutritional supplement unit dosage form, wherein the oral nutritional supplement unit dosage form comprises about 1 mmol L-arginine, about 1 mmol oxo-proline, about 2 mmol L-lysine, about 1.5 μmol N-acetyl L-cysteine, about 2 μmol L-glutamine, and about 125 μg schizonepeta (aerial parts) powder; and

orally administering an effective amount of the nutritional supplement to the human being.

2. The method according to claim 1 , wherein the oral nutritional supplement unit dosage form comprises:

about 0.9 mmol L-arginine;

about 1.3 mmol oxo-proline;

about 2.0 mmol L-lysine;

about 1.5 μmol N-acetyl L-cysteine;

about 1.7 μmol L-glutamine; and

about 1.25 μg schizonepeta (aerial parts) powder.

3. The method according to claim 2 , wherein the oral nutritional supplement unit dosage form comprises about 181 mg L-arginine HCl; about 170 mg L-pyroglutamic acid; about 374 mg L-lysine HCl; about 0.25 mg N-acetyl L-cysteine USP; about 0.25 mg L-glutamine, and about 0.125 mg schizonepeta (aerial parts) powder.

4. The method according to claim 1 , wherein the oral nutritional supplement unit dosage form is administered to the human being to further: increase pregnancy rate; increase live birth rate; increase lean body mass or libido; reduce obesity, adipose tissue mass, or anxiety; support weight loss; decrease appetite and atrophic processes in skeletal muscle, liver, kidney, spleen, skin, or bone; improve energy, endurance, sleep, metabolism, heart rate, blood pressure, cardiovascular health, sympathetic nervous activity, thyroid response, fat metabolism, glucose utilization, mental/cognitive function, reaction time, bone density, hair health and appearance, nail health and appearance, skin health and appearance, or libido; and/or affect one or more condition(s) and/or disease(s) that depend upon androgen activity in the human being.

5. The method according to claim 1 , wherein the oral nutritional supplement unit dosage form is orally administered in a total amount of about 2.9 grams.

6. The method according to claim 1 , wherein the oral nutritional supplement is administered from one to three times daily.

7. The method according to claim 1 , wherein the oral nutritional supplement is administered once a week.

8. The method according to claim 1 , wherein the human being is at least 30 years old.

9. The method according to claim 1 , wherein the human being exhibits one or more symptoms of hGH deficiency.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2023
From: CASPAR CAPITAL LP
To: QUALITY IP HOLDINGS LLC
Reel/Frame 062283/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: CERBERUS BUSINESS FINANCE, LLC
To: CASPAR CAPITAL LP
Reel/Frame 061636/0625 →
SECURITY INTEREST Recorded Jan 31, 2020
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051689/0553 →
SECURITY INTEREST Recorded Jan 31, 2020
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051689/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2018
From: HEATON, AMY L; FRIEDLANDER, MITCHELL K; GAY, DENNIS
To: QUALITY IP HOLDINGS, LLC
Reel/Frame 047523/0348 →
Continuity (3)
Continuation In Part 14301219 · Jun 10, 2014
Division 13623105 · Sep 19, 2012
Related Publication 20160256506A1 · Sep 8, 2016